Used as a key intermediate in the synthesis of biologically active compounds, particularly in pharmaceuticals targeting central nervous system disorders. Its structure enables incorporation into molecules with anticonvulsant, anxiolytic, or antidepressant properties. The sulfonamide group enhances binding affinity to certain enzymatic targets, making it valuable in drug design for neuropharmacological agents. Also explored in the development of novel sulfonamide-based therapeutics with improved metabolic stability and blood-brain barrier penetration.